Clinical Trial Update: Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

This completed clinical trial update reports on acute hemostasis after using the AQUABEAM System to treat benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• AQUABEAM System

Snippet

Sponsor: PROCEPT BioRobotics | Conditions: Benign Prostatic Hyperplasia | NA | Status: COMPLETED